|
English
|
|
Investisseurs
|
|
LABU - Direxion Funds: an ETF
DIREXION SHARES ETF TRUST DIREXION DAILY S&P BIOTECH BULL 3X SHARES
NYSE Arca
Fund Family: Direxion Funds
LABU Overview : An ETF with a x3 leverage factor
Leveraged ETF
Higher Risk ETF
Leveraged Factor: 3x
Category: Trading--Leveraged Equity
Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Leveraged exchange-traded funds (ETFs) are designed to achieve their investment objective on a daily basis meaning that they are not designed to track the underlying index over an extended period of time. Leverage can increase volatility. Inverse ETFs attempt to deliver returns that are the opposite of the underlying index's returns. Typically, the longer you hold a Leveraged or Inverse ETF, the greater your potential loss. Accordingly, Leveraged and Inverse ETFs may not be suitable for investors who plan to hold positions for longer than one trading session. These products are designed for highly experienced traders who understand their risks, including the impact of daily compounding of leveraged investment returns, and who actively monitor their positions throughout the trading day. Please read the Prospectus carefully before making your final investment decision.
Learn about the risks and mechanics of leveraged ETFs, click here.
Leveraged ETF
Higher Risk ETF
Leveraged Factor: 3x
Category: Trading--Leveraged Equity
Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Leveraged exchange-traded funds (ETFs) are designed to achieve their investment objective on a daily basis meaning that they are not designed to track the underlying index over an extended period of time. Leverage can increase volatility. Inverse ETFs attempt to deliver returns that are the opposite of the underlying index's returns. Typically, the longer you hold a Leveraged or Inverse ETF, the greater your potential loss. Accordingly, Leveraged and Inverse ETFs may not be suitable for investors who plan to hold positions for longer than one trading session. These products are designed for highly experienced traders who understand their risks, including the impact of daily compounding of leveraged investment returns, and who actively monitor their positions throughout the trading day. Please read the Prospectus carefully before making your final investment decision.
Learn about the risks and mechanics of leveraged ETFs, click here.